GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,983,000 | -1.2% | 91,441 | 0.0% | 0.31% | +7.5% |
| Q4 2021 | $4,033,000 | +15.1% | 91,441 | -0.3% | 0.29% | +13.2% |
| Q3 2021 | $3,505,000 | -5.1% | 91,723 | -1.1% | 0.26% | +1.2% |
| Q2 2021 | $3,694,000 | +10.6% | 92,766 | -0.9% | 0.26% | -0.8% |
| Q1 2021 | $3,341,000 | -5.2% | 93,617 | -2.2% | 0.26% | -10.5% |
| Q4 2020 | $3,524,000 | -1.9% | 95,752 | +0.4% | 0.29% | -17.1% |
| Q3 2020 | $3,591,000 | -3.3% | 95,402 | +4.8% | 0.35% | -11.5% |
| Q2 2020 | $3,712,000 | +7.1% | 90,994 | -0.5% | 0.39% | -10.5% |
| Q1 2020 | $3,467,000 | -19.4% | 91,494 | -0.0% | 0.44% | +18.4% |
| Q4 2019 | $4,300,000 | +5.7% | 91,504 | -4.0% | 0.37% | -2.4% |
| Q3 2019 | $4,069,000 | +1.3% | 95,334 | -5.0% | 0.38% | +6.8% |
| Q2 2019 | $4,016,000 | -3.9% | 100,359 | +0.3% | 0.35% | -4.1% |
| Q1 2019 | $4,181,000 | +9.4% | 100,044 | +0.0% | 0.37% | -9.6% |
| Q4 2018 | $3,822,000 | -1.3% | 100,021 | +3.8% | 0.41% | +28.3% |
| Q3 2018 | $3,871,000 | -0.3% | 96,356 | 0.0% | 0.32% | -8.4% |
| Q2 2018 | $3,884,000 | +3.4% | 96,356 | +0.2% | 0.35% | +10.9% |
| Q1 2018 | $3,757,000 | +15.4% | 96,156 | +4.7% | 0.31% | +22.3% |
| Q4 2017 | $3,256,000 | -17.0% | 91,796 | -5.0% | 0.26% | -20.5% |
| Q3 2017 | $3,922,000 | +2.4% | 96,592 | +8.8% | 0.32% | -0.9% |
| Q2 2017 | $3,829,000 | +3.2% | 88,807 | +1.0% | 0.32% | +6.6% |
| Q1 2017 | $3,709,000 | +32.9% | 87,969 | +21.4% | 0.30% | +36.8% |
| Q4 2016 | $2,791,000 | -33.5% | 72,481 | -25.5% | 0.22% | -38.6% |
| Q3 2016 | $4,195,000 | +25.6% | 97,265 | +26.2% | 0.36% | +25.6% |
| Q2 2016 | $3,341,000 | +1.6% | 77,080 | -5.0% | 0.29% | +2.5% |
| Q1 2016 | $3,290,000 | +4.0% | 81,130 | +3.7% | 0.28% | +6.4% |
| Q4 2015 | $3,163,000 | +5.2% | 78,230 | 0.0% | 0.26% | -2.6% |
| Q3 2015 | $3,008,000 | -94.9% | 78,230 | +3089.2% | 0.27% | +25.3% |
| Q2 2015 | $58,905,000 | +2523.8% | 2,453 | -95.0% | 0.22% | +26.9% |
| Q1 2015 | $2,245,000 | – | 48,655 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |